- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
ISG and Carl Zeiss finalize joint venture
Acquisition will expand DI’s coverage in TexasISG Technologies and optics firm Carl Zeiss have formalized their joint-venture agreement to form Surgical Navigation Specialists (SNS), an image-guided surgery company (SCAN 7/22/98). ISG
Acquisition will expand DIs coverage in Texas
ISG Technologies and optics firm Carl Zeiss have formalized their joint-venture agreement to form Surgical Navigation Specialists (SNS), an image-guided surgery company (SCAN 7/22/98). ISG holds an 80% share in the company, which was formed to produce and market ISGs Windows NT-based image-guided surgery software for the Surgical Navigation Network, a group of medical equipment firms that sell the software.
ISG, of Mississauga, Ontario, will contribute its image-guided surgery technology and assets, as well as its existing sales, marketing, and engineering staff. Thornwood, NY-based Zeiss will contribute technology, working capital, and marketing resources, according to the two firms
In other ISG news, the company moved into the black in its 1998 fiscal year. For the period (end-June), the company had net income of $327,000 (U.S.) compared with a net loss of $2.1 million last year. The company also saw its revenues climb 17% to a record high of $23.7 million during the campaign. Revenues in fiscal year 1997 were $20.2 million.
The company also had a strong fourth quarter. For the period, revenue was $6.6 million, up 12.1% compared with the $5.9 million in sales reported in the same period last year. Net income was $131,000 compared with a profit of $66,000 in 1997.
Four Strategies to Address the Tipping Point in Radiology
January 17th 2025In order to flip the script on the impact of the radiology workforce shortage, radiology groups and practices need to make sound investments in technologies and leverage partnerships to mitigate gaps in coverage and maximize workflow efficiencies.
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI-Based AI Enhance Risk Stratification in Prostate Cancer?
January 13th 2025Employing baseline MRI and clinical data, an emerging deep learning model was 32 percent more likely to predict the progression of low-risk prostate cancer (PCa) to clinically significant prostate cancer (csPCa), according to new research.
